Patent ID: 7595380

Claim:
A monoclonal antibody that is capable of specifically binding to MCM2, wherein the antibody is selected from the group consisting of: (a) the monoclonal antibody produced by the hybridoma cell line 27C5.6, deposited with the ATCC as Patent Deposit No. PTA-6668; (b) the monoclonal antibody produced by the hybridoma cell line 26H6.19, deposited with the ATCC as Patent Deposit No. PTA-6667; (c) a monoclonal antibody that binds to the amino acid sequence set forth in SEQ ID NO:3; (d) a monoclonal antibody that binds to the amino acid sequence of SEQ ID NO:14; and (e) an antigen binding fragment of a monoclonal antibody of (a)-(d), wherein the fragment retains the capability of specifically binding to MCM2.